We are live on
!
Find out more
RM
RP Management Portfolio holdings
AUM
$139M
1-Year Est. Return
37.98%
This Fund
S&P 500
This Quarter
Est. Return
+83.1%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$381M
AUM Growth
+$225M
(+144%)
Cap. Flow
+$99M
Cap. Flow
% of AUM
25.99%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
+$99M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 75.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1
DELISTED
Epizyme, Inc
EPZM
| $164M | 43.07% |
+6,666,667
| New | +$99M |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $115M | 30.18% |
2,111,111
| – | – |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $92.5M | 24.3% |
4,373,178
| – | – |
|
4
Cytokinetics
CYTK
$11.5B
| $9.29M | 2.44% |
875,656
| – | – |
|
|
VIRX
5
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $44K | 0.01% |
3,700
| – | – |
|
Similar funds
PC
LA
TP
SC
MFG
MADFP
RM
NC